212 related articles for article (PubMed ID: 27347211)
1. Methylation status of the
Matthaios D; Balgkouranidou I; Karayiannakis A; Bolanaki H; Xenidis N; Amarantidis K; Chelis L; Romanidis K; Chatzaki A; Lianidou E; Trypsianis G; Kakolyris S
Oncol Lett; 2016 Jul; 12(1):748-756. PubMed ID: 27347211
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
3. Impact of
Jezkova E; Zubor P; Kajo K; Grendar M; Dokus K; Adamkov M; Lasabova Z; Plank L; Danko J
Oncol Lett; 2017 Jul; 14(1):758-766. PubMed ID: 28693231
[TBL] [Abstract][Full Text] [Related]
4. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
5. [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer].
Li M; Yan DG; Liu JL
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):456-9. PubMed ID: 26875923
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients.
Nilsson TK; Löf-Öhlin ZM; Sun XF
Int J Oncol; 2013 Jan; 42(1):127-33. PubMed ID: 23128528
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients.
Karamitrousis EI; Balgkouranidou I; Xenidis N; Amarantidis K; Biziota E; Koukaki T; Trypsianis G; Karayiannakis A; Bolanaki H; Kolios G; Lianidou E; Kakolyris S
Technol Cancer Res Treat; 2021; 20():1533033820973279. PubMed ID: 33928818
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
9. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
[TBL] [Abstract][Full Text] [Related]
10. Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.
Zare M; Jazii FR; Alivand MR; Nasseri NK; Malekzadeh R; Yazdanbod M
BMC Cancer; 2009 Jan; 9():24. PubMed ID: 19149902
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
12. Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism.
Coppedè F; Migheli F; Lopomo A; Failli A; Legitimo A; Consolini R; Fontanini G; Sensi E; Servadio A; Seccia M; Zocco G; Chiarugi M; Spisni R; Migliore L
Epigenetics; 2014 Apr; 9(4):621-33. PubMed ID: 24500500
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor.
Ohshima J; Haruta M; Fujiwara Y; Watanabe N; Arai Y; Ariga T; Okita H; Koshinaga T; Oue T; Hinotsu S; Nakadate H; Horie H; Fukuzawa M; Kaneko Y
Pediatr Blood Cancer; 2012 Sep; 59(3):499-505. PubMed ID: 22457227
[TBL] [Abstract][Full Text] [Related]
14. Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
Jezkova E; Kajo K; Zubor P; Grendar M; Malicherova B; Mendelova A; Dokus K; Lasabova Z; Plank L; Danko J
Tumour Biol; 2016 Oct; ():. PubMed ID: 27744628
[TBL] [Abstract][Full Text] [Related]
15. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
16. Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.
Sun X; Yuan W; Hao F; Zhuang W
Med Sci Monit; 2017 Nov; 23():5389-5395. PubMed ID: 29128865
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.
Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES
Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954
[TBL] [Abstract][Full Text] [Related]
18. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative detection of APC/RASSF1A promoter methylation in the plasma of patients with cervical diseases].
Wang H; Pan SY; Pang ZR; Wang F; Xu J; Chen D; Xie EF; Zhang LX; Gao L; Xu YQ; Jin B
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):929-34. PubMed ID: 24495688
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]